Research in Translation

Research in Translation Research in Translation articles discuss a particular drug, treatment, or public health intervention in the context of translation from early research to clinical research, or clinical evidence to practice.

See all article types »

Cell-Based Bone Tissue Engineering

  • Gert J Meijer mail,

    To whom correspondence should be addressed. E-mail:

  • Joost D de Bruijn,
  • Ron Koole,
  • Clemens A van Blitterswijk
  • Published: February 20, 2007
  • DOI: 10.1371/journal.pmed.0040009

About the Authors

Corresponding Author


Competing Interests

JDB is founder of Progentix BV. CAB is co-founder of IsoTis SA, Progentix BV, and CAM implants BV, which are all active in bone substitution, and has some financial interest in the first two companies. These companies had no role in the decision to submit this paper, or in its preparation. GJM and RK declare that they have no competing interests.